PLENARY SESSIONS
THURSDAY, NOVEMBER 21

14:00-15:00 THE BEST OF RBMO 2018-2019
Hall A
Capsule The three best papers published in RBMO in 2018 are presented in this session
Chairperson Bart Fauser, Netherlands
14:00-14:20 An evidence-based scoring system for prioritizing mosaic aneuploid embryos following preimplantation genetic screening
Francesca Grati, Italy
14:20-14:40 Predicting live birth for poor ovarian responders: the PROsPeR concept
Philippe Lehert, Australia
14:40-15:00 The impact of antenatal Bisphenol A exposure on male reproductive function at 20–22 years of age
Roger J. Hart, Australia
15:00-16:15 INTERVENTIONS THAT MATTER IN PREGNANCY MAINTENANCE
A PREIS SCHOOL ACADEMY SESSION
Hall A
Capsule Prevention of repeated abortion and preterm birth: Any similarities?
Chairpersons Giancarlo Di Renzo, Italy
Kypros Nicolaides, UK
15:00-15:25 What do  we know about preventing threatened abortion and recurrent miscarriage?
Adam Devall, UK
15:25-15:50 Is “Aspirin” valuable only for preventing preeclampsia or also for preterm birth?
Kypros Nicolaides, UK
15:50-16:15 Cannabis in pregnancy
Michael Dor, Israel
16:15-16:45 INDUSTRY SUPPORTED SESSION
Hall A
16:45-18:30 HOT CONTROVERSIES IN INFERTILITY TREATMENTS Hall A
Chairpersons Rene Frydman, France
Zion Ben Rafael, Israel
Bart Fauser, Netherlands
Capsule Reproduction is a delicate balancing act. A viable embryo must interact with a receptive endometrium. A small window of opportunity during which the embryo orchestrates its attachment and fate exists. Insight to this process could improve Implantation rates and pregnancy success overall.  For simplicity, the coordination of the process has been historically attributed to estrogen, progesterone and to embryo quality. Is it that simple?
16:45-17:15 Is it the embryo or the endometrium?
Pregnancy: Embryo-led maternal adaptive response. PIF determining regulatory role
Eytan Barnea, USA
Capsule Human embryo genome editing holds great promise to cure several diseases and avoid the necessity of discarding embryos.  In addition, whole chromosome editing may rescue aneuploid embryos from patients of advanced maternal age.  However, recent events have hampered progress in the field, with many calling for a global moratorium on both research and clinical development. How far should we go with this?
17:15-17:45 Human embryo gene editing
Nathan Treff, USA
Capsule The microbiome is the big unknown, the “elephant in the room” of reproduction and pregnancy care. What do we know. What do we have to know?
17:45-18:15 Reproductive tract microbiome and its relevance to pregnancy outcome and neonatal/post-natal development
Jerome Strauss, USA
Capsule 2020 will mark the launching of the international cervical cancer elimination campaign. The role of the health care providers will be examined
18:15-18:30 Milestones towards cervical cancer elimination
Xavier Bosch, Spain
18:30-19:30 OPENING SESSION: NOBEL PRIZE LAUREATE ROBERT G. EDWARDS ANNUAL LECTURE Hall A
Capsule PCOS is a life-long reproductive disorder, which is extremely prevalent but is often underdiagnosed, in part because of its heterogeneity, and due to the existence of various phenotypes.  Although there remains large gaps in our knowledge base, the transition of PCOS  from adolescence to menopause and beyond will be discussed.
Chairpersons Zion Ben Rafael, Israel
Bart Fauser,
Netherlands
Rene Frydman,
France
18:30-19:15 Nobel Prize Laureate Robert G. Edwards Annual Lecture:
PCO/PCOS , before during and after reproductive life
Roger A. Lobo, USA
19:15-19:30 Best Abstract Award Ceremony
19:30-20:15 Network Reception